Back
HFA Premium Access

Two year follow-up results from AUGMENT-HF: a multicenter randomized controlled clinical trial of the efficacy of left ventricular augmentation with algisyl in the treatment of heart failure.

Session: Late Breaking Trials III: Innovative and device therapies
Topic: Miscellaneous
Speaker: Professor A. Stewart Coats (Sydney, AU)
Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Congress Presentation

About the speaker

Professor Andrew Stewart Coats

Heart Research Institute, Sydney (Australia)
111 presentations
21 followers

9 more presentations in this session

The subset of patients with acute heart failure able to secrete relaxin-2 at pregnancy concentrations could have a longer survival.

Speaker: Doctor O. Miro (Barcelona, ES)

Access
Slides
Video
Thumbnail

Discussion: RELAXIN-2.

Access
Video
Thumbnail

The HeartLogic multi-sensor algorithm as an automatic predictor of heart failure events: results from the MultiSENSE Trial.

Speaker: Professor R. Gardner (Clydebank, GB)

Access
Slides
Video
Thumbnail

Discussion: MultiSENSE.

Access
Video
Thumbnail

Cardiopoietic stem cell therapy improved left ventricular remodeling: longitudinal results from the CHART-1 study.

Speaker: Professor J. Teerlink (San Francisco, US)

Access
Slides
Video
Thumbnail

Access the full session

Late Breaking Trials III: Innovative and device therapies

Speakers: Professor A. Stewart Coats, Doctor O. Miro, Professor R. Gardner, Professor J. Teerlink
Access
Thumbnail

About the event

Image

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb